Literature DB >> 25211328

Increased DNA damage in hepatitis C virus-related hepatocellular carcinoma.

Shereen M Shawki1, Safa S Meshaal, Aliaa S El Dash, Naglaa A Zayed, Mariam Onsy F Hanna.   

Abstract

One consequence of hepatitis C virus (HCV) infection is an elevated cancer risk. During chronic viral infection, deoxyribonucleic acid (DNA) damage is being induced by reactive oxygen and nitrogen species, which may play a pathogenic role in HCV-induced carcinogenesis. The study investigated DNA damage in peripheral blood lymphocytes from patients with hepatocellular carcinoma (HCC) and those with HCV infection with and without associated cirrhosis and normal controls. As a measure for genomic damage, the comet assay (single cell gel electrophoresis) was applied, which detects single- and double-strand breaks and alkali-labile sites through electrophoretic mobility of the resulting fragments. The levels of DNA damage were significantly higher in HCC and HCV-associated cirrhosis compared to HCV without cirrhosis and the control group. Patients presenting with DNA damage more than mean+two standard deviation of the controls had a 3.6-fold risk of having HCC more than those with undamaged DNA. HCV disease progression was the only discriminator predicting the extent of DNA damage. The accumulation of DNA damage is important in HCC evolution. DNA damage indicating intracellular oxidative and nitrative stress may lead to mutagenesis and consequently malignant transformation, which emphasizes the need to optimize the therapy for reducing the degree of genomic damage.

Entities:  

Mesh:

Year:  2014        PMID: 25211328     DOI: 10.1089/dna.2014.2417

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  4 in total

1.  Enhancer of rudimentary homolog regulates DNA damage response in hepatocellular carcinoma.

Authors:  Meng-Tzu Weng; Tzu-Hsun Tung; Jih-Hsiang Lee; Shu-Chen Wei; Hang-Li Lin; Yu-Jung Huang; Jau-Min Wong; Ji Luo; Jin-Chuan Sheu
Journal:  Sci Rep       Date:  2015-04-09       Impact factor: 4.379

2.  Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs.

Authors:  Mohamed Tharwat Hegazy; Walaa Ramadan Allam; Mohamed A Hussein; Naguib Zoheir; Luca Quartuccio; Sherif F El-Khamisy; Gaafar Ragab
Journal:  EBioMedicine       Date:  2018-08-20       Impact factor: 8.143

3.  Ligation-Mediated Polymerase Chain Reaction Detection of 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine and 5-Hydroxycytosine at the Codon 176 of the p53 Gene of Hepatitis C-Associated Hepatocellular Carcinoma Patients.

Authors:  Andrea Galli; Armelle Munnia; Filippo Cellai; Mirko Tarocchi; Elisabetta Ceni; Frederik Jan van Schooten; Roger Godschalk; Roger W Giese; Marco Peluso
Journal:  Int J Mol Sci       Date:  2020-09-15       Impact factor: 5.923

4.  Hepatitis C virus promotes hepatocellular carcinogenesis by targeting TIPE2, a new regulator of DNA damage response.

Authors:  Yaohui Wang; Yinan Jiang; Jinxue Zhou; Wuhui Song; Jing Li; Mingli Wang; Jiuge Chen; Rui Xu; Jingjing Zhang; Fanni Ma; Youhai H Chen; Yuanfang Ma
Journal:  Tumour Biol       Date:  2016-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.